Chemosaturation therapy is a non-surgical treatment for cancer of the liver. Using X-ray guidance, an anti-cancer drug (chemotherapy) is delivered directly to the liver, whilst the blood supply to the liver is sealed off to prevent the spread of the drug to the rest of the body.
It can target not only visualised tumours in the liver, but even those that are non-visualised. Once the liver has been saturated in the chemotherapy, the blood is haemofiltrated to remove as much of the chemotherapy agent as possible to minimise the associated side effects that come with conventional delivery methods of chemotherapy.
Chemosaturation is suitable for patients with primary liver cancer and metastatic liver cancer (cancer that starts in another part of your body and then spreads to the liver). Your doctor will discuss with you whether you are suitable for chemosaturation therapy. This will depend on a number of factors including (but not limited to) the stage and grade of your cancer, your age and overall health, how much cancer you have and whether it is mainly in the liver.
Chemosaturation therapy in particular has been shown to prolong life in patients with ocular melanoma where the cancer has spread to the liver.